middle.news
How Patrys Is Racing to Launch Injectable Delirium Therapy by H2 2026
8:34am on Wednesday 11th of March, 2026 AEDT
•
Healthcare
Read Story
How Patrys Is Racing to Launch Injectable Delirium Therapy by H2 2026
8:34am on Wednesday 11th of March, 2026 AEDT
Key Points
Engineering batch manufacturing started at BioCina
US regulatory engagement underway ahead of FDA pre-IND submission
CRO selection in progress for Phase 0 clinical trial
Clinical trial initiation targeted for H2 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
PATRYS (ASX:PAB)
OPEN ARTICLE